Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

NCT01894477 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia in Remission
Chronic Myelomonocytic Leukemia
Minimal Residual Disease
Myelodysplastic Syndrome
Myelodysplastic/Myeloproliferative Neoplasm
Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable

Interventions

PROCEDURE: Allogeneic Bone Marrow Transplantation
DRUG: Fludarabine Phosphate
PROCEDURE: Peripheral Blood Stem Cell Transplantation
RADIATION: Total-Body Irradiation
DRUG: Treosulfan
OTHER: Laboratory Biomarker Analysis

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]
[object Object]